Cargando…
Intra-arterial delivery of mesenchymal stem cells
While treatments have been developed to combat stroke, such as intravenous recombinant tissue plasminogen activator and endovascular recanalization therapies, their ability to decrease the long-term disability that accompanies stroke is limited. Currently, stem cell research focused on mesenchymal s...
Autores principales: | Watanabe, Mitsuyoshi, Yavagal, Dileep R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126270/ https://www.ncbi.nlm.nih.gov/pubmed/30276284 http://dx.doi.org/10.4103/2394-8108.192522 |
Ejemplares similares
-
Efficacy and Dose-Dependent Safety of Intra-Arterial Delivery of Mesenchymal Stem Cells in a Rodent Stroke Model
por: Yavagal, Dileep R., et al.
Publicado: (2014) -
Cell Therapy of Stroke: Do the Intra-Arterially Transplanted Mesenchymal Stem Cells Cross the Blood–Brain Barrier?
por: Yarygin, Konstantin N., et al.
Publicado: (2021) -
Unexpected Internal Mammary Artery Perforation During Transradial Access for a Neuroendovascular Procedure
por: Abecassis, Isaac Josh, et al.
Publicado: (2021) -
THERAPEUTIC EFFICACY OF INTRA-ARTICULAR DELIVERY OF ENCAPSULATED HUMAN MESENCHYMAL STEM CELLS ON EARLY STAGE OSTEOARTHRITIS
por: McKinney, J.M., et al.
Publicado: (2019) -
The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity
por: Cui, Li-li, et al.
Publicado: (2015)